Irinotecan Injection IP

Product Description

Avail from us Irinotecan Injection IP (Irinotel Injection) which is used to treat cancer as an antineoplastic agent. It is available in pale, yellow color with the pH value adjusted to the range of 3.5. If comes in skin contact, it is advised to clean the hand with soap and water, before carrying out any other activity. Patients are advised to take the medicine in prescribed dosage, as failure to do so can cause chest pain, dry cough, feeling short of breath, and more. You need to keep this product in cool and dry place for enhanced shelf-life. Irinotecan is injected intravenously (IV) and is given. The precise dosage and administration schedule are set by the treating oncologist based on the patients unique condition, the kind of cancer being treated, and other variables. Features of Irinotecan Injection IP: Irinotecan is a chemotherapy medicine that is given intravenously, which means it is injected right into the bloodstream to target cancer cells all over the body. Irinotecan works by blocking the activity of topoisomerase I, an enzyme required for DNA replication and repair in cancer cells. Cancer cells are killed by this interference, which also reduces the growth of tumors. Irinotecan is frequently used in the management of advanced colorectal cancer that has metastasized to other areas of the body or recurred following first treatment. Combination therapy: To increase the effectiveness of the treatment, it is frequently used in conjunction with other chemotherapeutic medicines or targeted therapies. Benefits of Irinotecan Injection IP: Cancer cell death: Irinotecan targets and inhibits topoisomerase I, which interferes with cancer cells DNA synthesis and repair processes, killing them and halting tumor development. Extended survival: Compared to traditional therapies, irinotecan has been demonstrated to prolong the lives of patients with advanced colorectal cancer in clinical studies and in real-world settings. Palliative care: When cancer has spread to an advanced stage and cannot be cured, irinotecan can help patients manage their symptoms, enhance their quality of life, and provide palliative care. Irinotecan is frequently used in conjunction with other chemotherapeutic medications or targeted therapies, improving the treatment response overall and raising the likelihood of tumor shrinking. While mainly utilized in colorectal cancer, there is a chance that it could be used in other malignancies as well.